-
Osobe Vidi sve
Ovjeren akaunt@genentech Official Twitter Site for Genentech. See our community guidelines here: http://ow.ly/1sSw30lmszz
USA • gene.com
-
Please RT! Structural Biology at
#Genentech is looking for a protein expression & purification wizard to join its ranks. Amazing opportunity to join a stunning research environment and help discover new drugs while solving structures! http://www.gene.com/careers/detail/201904-111125/Scientist … -
$XNCR to Develop and Commercialize Novel IL-15 Immune Activating Cytokines with#Genentech. Xencor To receive $120M Up-front.$RHHBYhttps://finance.yahoo.com/news/xencor-develop-commercialize-novel-il-130100309.html … -
$CYCC in GBM recognized by leading#genentech scientist Avi Ashkenazi which concluded that " provide evidence that the CDK inhibitor successfully crossed the blood brain barrier of the tumour bearing animals" pic.twitter.com/bSQVht4f4r
-
Adaptive Biotechnologies Enter into Worldwide Collab & LA w/
#Genentech to Develop Personalized Cellular Therapies for the Treatment of Cancer. $300M upfront to Adaptive$RHHBY$ROGhttps://www.businesswire.com/news/home/20190104005112/en/Adaptive-Biotechnologies-Enter-Worldwide-Collaboration-License-Agreement … -
Genentech Gives Bank Concert with the familia
#genentech @ Oracle Park https://www.instagram.com/p/BzBesEbhIod/?igshid=1hao3lunww4cp … -
Jan 6, 2015
“A deal announced with #Genentech points the way for#23andMe, the personal genetics company backed by@Facebook [& Mail .RU] billionaire#YuriMilner and#GoogleVentures to become a sustainable business”https://www.fiercebiotech.com/medtech/23andme-therapeutics-leader-leaves-for-board-roles-at-up-and-coming-biotechs … -
Thanks to
#Genentech for promoting the importance of culture. It’s my honor to be one of their speakers. https://lnkd.in/ent9F2y -
Very interesting article on paying and giving away your
#DNA /#CoreIdentity to companies who sell it on!#JMKSunday#JMK_Sunday#OSINT#Ancestry#Health#Privacy#23andme#MyHeritage#Genentech https://www.bbc.com/news/technology-48110894 … -
$CYCC today news.#Genentech Submits Application for Venclexta (Venetoclax ) Plus Gazyva for CLL$RHHBY$ABBV.. what$CYCC will do in the future is replace Gazyva from the combination. so$RHHBY may also be a suitor for$CYCC .. MORE HEREhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826810/ … -
Our friends at
@HDBuzzFeed breakdown the latest announcement from#Roche /#Genentech Roche announces an update to the GENERATION HD1 trial after reviewing the ASO open label extension study Full Story: https://en.hdbuzz.net/272#HuntingtonsDisease#HDSAFamily#LetsTalkAboutHDpic.twitter.com/tZUMYeIXaO
-
Structural Basis of
#Nav1pt7 Inhibition by a Gating-Modifier Spider#Toxin - ScienceDirect. Congratulations on a great paper from the guys & gals at#Genentech.#ionchannels#xtal#crystal#knottins#voltagesensing#chronicpain https://www.sciencedirect.com/science/article/pii/S0092867418316325 … -
(A) approved for all forms of MS (B) High efficacy (C) probably safer than natalizumab and alemtuzumab. Can we all agree this drug has the best B/R ratio?
#Ocrevus#Genentech
-
Can’t be more excited about starting my internship at
#Genentech !#machinelearning#internshippic.twitter.com/h81P6uKK7Y
-
So excited for
#ASH19 ... proud to have 5 presentations, including the one on#mosunetuzumab#biomarkers, which I led while I was at#genentech pic.twitter.com/iCdZYK79Md
-
#Genentech’s Tecentriq Wins Approval for ES-SCLC, Its Second of the Month https://hubs.ly/H0h3S3r0 pic.twitter.com/ZoWkuMhqVK
-
#DiversityInClinicalTrials a great panel discussion on issues and opportunity to improve inclusivity in research to get Better Science and Better Medicine. Thanks to#Genentech our sponsor and#HBAImpactpic.twitter.com/1LY1e7oWjB
-
Can’t believe we said goodbye to
@LaneO714 today (for real). The 1st#LundLab grad student - feels like the biggest milestone yet. Can’t wait to see what you do Ryan! Good luck at#Genentech with@TurleyLabGNE ... and ... go 49ers??pic.twitter.com/J2fzEJpyDy
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.